Participant and GP perspectives and experiences of screening for undiagnosed type 2 diabetes in community pharmacy during the Pharmacy Diabetes Screening Trial

BACKGROUND: The Pharmacy Diabetes Screening Trial (PDST) evaluated three approaches to screening for undiagnosed type 2 diabetes mellitus (T2DM) in community pharmacy: (1) paper-based risk assessment (AUSDRISK) alone; and AUSDRISK followed by a point of care test if AUSDRISK ≥ 12; with either (2) Hb...

Descripción completa

Detalles Bibliográficos
Autores principales: Krass, Ines, Twigg, Michael J., Mitchell, Bernadette, Wilson, Frances, Mohebbi, Mohammadreza, Trinder, Peta, Shih, Sophy T. F., Carter, Rob, Versace, Vincent L., McNamara, Kevin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693079/
https://www.ncbi.nlm.nih.gov/pubmed/38041094
http://dx.doi.org/10.1186/s12913-023-10269-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693079/
https://www.ncbi.nlm.nih.gov/pubmed/38041094
http://dx.doi.org/10.1186/s12913-023-10269-1

Ejemplares similares